|
Volumn 14, Issue 2 SUPPL. 2, 1996, Pages 32-38
|
Neoadjuvant total androgen suppression and radiotherapy in the management of locally advanced prostate cancer
|
Author keywords
Prostate cancer; radiation; total androgen suppression
|
Indexed keywords
FLUTAMIDE;
GOSERELIN;
MEGESTROL;
PROSTATE SPECIFIC ANTIGEN;
ADVANCED CANCER;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER HORMONE THERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DIARRHEA;
HOT FLUSH;
HUMAN;
MALE;
MULTIMODALITY CANCER THERAPY;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATECTOMY;
TREATMENT OUTCOME;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
CHEMOTHERAPY, ADJUVANT;
DISEASE-FREE SURVIVAL;
HUMANS;
MALE;
NEOPLASM STAGING;
PROGNOSIS;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
RADIOTHERAPY, ADJUVANT;
TREATMENT OUTCOME;
|
EID: 0029974256
PISSN: 10810943
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (12)
|
References (0)
|